Skip to main content

Table 2 Incremental cost-effectiveness

From: Cost-effectiveness analysis of a cluster-randomized, culturally tailored, community health worker home-visiting diabetes intervention versus standard care in American Samoa

 

Costs

Effectiveness

Cost-effectiveness

 

Incremental costs

HbA1c reduced

QALYs gained

ICER (HbA1c)

ICER (QALYs)

Intervention

$594.27

0.53

0.05

$1121.26

$13 191.24

  1. Note: Incremental costs shown in Table 3